RYTM
Rhythm Pharmaceuticals, Inc. · Healthcare
CHRO Pamela J. Cramer sold $372K of Rhythm Pharmaceuticals, Inc.
Sold$371,850
$111.00Price
3,350Shares
−14%Stake
What RYTM did after the filing
- The stock from Mon, Dec 15 close, $112.52
- −7.8%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Jan 29 close.
Traded Thu, Dec 11. Filed Mon, Dec 15, 11:30 AM ET, during the session. Returns use the Dec 15 close and the Jan 29 close. Not investment advice.